UTI vs PXED
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
UTI
PXED
Investment Advisor Scores
PXED
AI Analyst Insights
Detailed Metrics Comparison
| Metric | UTI | PXED | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 29.2398 | 4.878 | PXED |
| PEG Ratio | 1.9511 | 0.4878 | PXED |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.2% | 1.3% | UTI |
| Earnings Growth | -78.9% | 33.1% | PXED |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.4/100 | 38.9/100 | UTI |
| Profit Margin | 3.9% | 8.7% | PXED |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | UTI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
UTI
NeutralMixed signals - no dominant trend phase, RSI 57
PXED
MarkdownPrice below a falling SMA50 (slope -7.9%), weak momentum, RSI 18
Fundamentals Snapshot
| Metric | UTI | PXED |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.3 | 4.4 |
| Trailing P/E | 38.0 | 8.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.6% | 0.6% |
| Operating Margin | 0.0% | 0.2% |
| EPS | 0.61 | 2.29 |
| Dividend Yield | — | 0.04% |